Rapt Therapeutics, Inc. (RAPT)
57.92
+0.12
(+0.21%)
USD |
NASDAQ |
Feb 20, 16:00
57.91
-0.01
(-0.02%)
After-Hours: 20:00
Rapt Therapeutics SG&A Expense (Quarterly) : 7.337M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Penumbra, Inc. | 168.90M |
| Amicus Therapeutics, Inc. | 117.08M |
| Johnson & Johnson | 6.753B |
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |